Skip to content

Clinical trials

Recruiting Phase 1/2 Anemia, Refractory, with Excess of Blasts trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Phase: Phase 1/2 Status: Recruiting Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20191
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
ARCE Therapeutics, Inc.1
Chaser Therapeutics, Inc.1
Children's Hospital of Philadelphia1
Institute of Hematology and Blood Transfusion, Czech Republic1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts7
Leukemia, Myeloid, Acute5
Leukemia, Biphenotypic, Acute2
Leukemia, Myelomonocytic, Chronic2
Myelodysplastic Syndromes2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Anemia, Aplastic1
Bone Marrow Diseases1
Bone Marrow Failure Disorders1
Congenital Bone Marrow Failure Syndromes1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.